Study details
Enrolling now
129Xe MRI Cardiopulmonary Trial
Bastiaan Driehuys
NCT IDNCT06038630ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
125
Study length
about 4.5 years
Ages
18+
Locations
1 site in NC
What this study is about
This trial is testing a new imaging technique using 129Xe gas to see how it changes in different lung conditions. The goal is to understand these changes and develop better ways to diagnose and treat lung diseases.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Oxygen Administration
- 2.Take Hyperpolarized Xe129
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
Diagnostic Agent (Imaging Contrast Activity), VARIOUS
Body systems
Cardiology / Heart